A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
Jacobio Pharmaceuticals Co., Ltd.
Jacobio Pharmaceuticals Co., Ltd.
Incyte Corporation
Merck Sharp & Dohme LLC
Pure Biologics S.A.
Xencor, Inc.
Incyte Corporation
Allist Pharmaceuticals, Inc.
Tvardi Therapeutics, Incorporated
RAPT Therapeutics, Inc.
Cyteir Therapeutics, Inc.
Astellas Pharma Inc
Xencor, Inc.
Prelude Therapeutics
Gene Surgery LLC
NextCure, Inc.
Corvus Pharmaceuticals, Inc.
OncoNano Medicine, Inc.
Tempest Therapeutics
Eastern Cooperative Oncology Group
Xencor, Inc.
Herlev Hospital
Mayo Clinic
Ludwig Institute for Cancer Research
Xencor, Inc.
Incyte Corporation
Incyte Corporation
Institut Bergonié
Novartis
Incyte Corporation
AstraZeneca
AbbVie
Alliance for Clinical Trials in Oncology
Millennium Pharmaceuticals, Inc.
Alliance for Clinical Trials in Oncology
OHSU Knight Cancer Institute
PCI Biotech AS
INSYS Therapeutics Inc
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
East and North Hertfordshire NHS Trust
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
National Institutes of Health Clinical Center (CC)